HR 6556
116th Congress
House
Health
Banking and financial institutions regulation
Child health
Civil actions and liability
Government trust funds
Health programs administration and funding
Medical research
Research administration and funding
Securities and Exchange Commission (SEC)
Gabriella Miller Kids First Research Act 2.0
Introduced: April 17, 2020
See on congress.gov
Everywhere this bill has been
3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Apr 17, 2020
Sponsor introductory remarks on measure. (CR E373)
Apr 17, 2020
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 17, 2020
Introduced in House
Plain-English summary
Gabriella Miller Kids First Research Act 2.0
This bill directs certain penalties assessed by the Securities Exchange Commission against pharmaceutical companies for specified violations to the 10-Year Pediatric Research Initiative Fund, an existing fund that supports pediatric disease research. In making allocations from that fund, the National Institutes of Health shall prioritize pediatric research that does not duplicate existing research activities.
What's happening now
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Committees of jurisdiction
2